Stratec SE (ETR:SBS - Get Free Report) shares dropped 0.9% on Monday . The stock traded as low as €27.40 ($31.86) and last traded at €27.70 ($32.21). Approximately 10,230 shares traded hands during mid-day trading, an increase of 64% from the average daily volume of 6,253 shares. The stock had previously closed at €27.95 ($32.50).
Stratec Trading Up 1.8%
The company's fifty day moving average price is €25.99 and its two-hundred day moving average price is €27.55. The company has a current ratio of 2.52, a quick ratio of 1.65 and a debt-to-equity ratio of 66.97. The firm has a market cap of $333.98 million, a P/E ratio of 33.36, a price-to-earnings-growth ratio of 10.43 and a beta of 0.16.
About Stratec
(
Get Free Report)
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.
Featured Articles
Before you consider Stratec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stratec wasn't on the list.
While Stratec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
